AI assistant
Sending…
BALCHEM CORP — Director's Dealing 2012
Dec 7, 2012
31041_dirs_2012-12-07_92309d77-7d97-441d-9099-9542fb33cf6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BALCHEM CORP (NASDAQ: BC)
CIK: 0000009326
Period of Report: 2012-12-03
Reporting Person: BENDURE RICHARD ALLEN (Chief Operating Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option | $35.79 | 2022-12-02 | Common Stock (50000) | Direct |
Footnotes
F1: Ownership of the restricted stock vests in Reporting Person on a straight-line basis 8.33% every ninety (90) days, during the three (3) years following the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person dated December 1, 2012.
F2: Options vest 20% year 1; 40% year 2; and 40% year 3
More from BALCHEM CORP
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 20
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 19